A Study of BL-M11D1 in Patients With Relapsed/Refractory Myelodysplastic Syndromes

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of BL-M11D1 in Patients With Relapsed/Refractory Myelodysplastic Syndromes	Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome	Not yet recruiting	Phase 1 / Phase 2	2026-08-27		NCT07591168

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.	110
Sichuan Baili Pharmaceutical Co., Ltd.	135

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences	Tianjin	China	2

Clinical trials